GDOC

Exchange-traded product on NYSE (US)

Type
Exchange-traded product
Share class
—
Status
listed
ISIN
—
Currency
—
Represents the company
No

Holdings as of Aug 31, 2026

41 lines, 38 linked, weights sum to 100.41% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
ELI LILLY & COMPANY LLY US5324571083 Equity 2,066 −351 12.19% $ 2.39M
JOHNSON & JOHNSON JNJ US4781601046 Equity 6,127 −1,077 8.31% $ 1.629M
MERCK & COMPANY INC MRK US58933Y1055 Equity 9,861 −212 7.44% $ 1.457M
UNITEDHEALTH GROUP INC UNH US91324P1021 Equity 2,912 +2,197 5.79% $ 1.134M
VERTEX PHARMACEUTICALS INC VRTX US92532F1003 Equity 1,511 +844 4.20% $ 822.77K
ARGENX SE ARGX US04016X1019 Equity 787 −192 4.14% $ 811.916K
GUARDANT HEALTH INC GH US40131M1099 Equity 4,952 −3,334 4.02% $ 787.467K
DEXCOM INC DXCM US2521311074 Equity 8,317 +696 3.86% $ 757.346K
AGILENT TECHNOLOGIES INC A US00846U1016 Equity 4,485 +380 3.51% $ 688.717K
THERMO FISHER SCIENTIFIC INC TMO US8835561023 Equity 1,114 −733 3.51% $ 687.449K
EDWARDS LIFESCIENCES CORP EW US28176E1082 Equity 7,509 +570 3.48% $ 681.442K
INTUITIVE SURGICAL INC ISRG US46120E6023 Equity 1,526 −323 2.93% $ 575.088K
LONZA GROUP AG LONN CH0013841017 Equity 771 −108 2.81% $ 550.23K
CENCORA INC COR US03073E1055 Equity 1,619 −131 2.67% $ 523.908K
ROIVANT SCIENCES LTD ROIV BMG762791017 Equity 14,044 −1,992 2.48% $ 486.484K
HOYA CORP 7741 JP3837800006 Equity 2,595 −1,578 2.04% $ 399.743K
ASTRAZENECA PLC AZN GB0009895292 Equity 2,440 −2,794 2.02% $ 395.986K
ROYALTY PHARMA PLC RPRX GB00BMVP7Y09 Equity 5,584 −786 1.75% $ 342.913K
METTLER-TOLEDO INTERNATIONAL INC MTD US5926881054 Equity 238 −33 1.71% $ 334.423K
REPLIGEN CORP RGEN US7599161095 Equity 1,789 −249 1.65% $ 323.773K
Goldman Sachs Trust
FTOXX US38141W3236 Money market 311,849.22 +23,860.64 1.59% $ 311.849K
CYTOKINETICS INC CYTK US23282W6057 Equity 4,355 +692 1.58% $ 308.813K
NATERA INC NTRA US6323071042 Equity 955 new +955 1.57% $ 307.472K
BOSTON SCIENTIFIC CORP BSX US1011371077 Equity 6,257 −9,483 1.54% $ 302.213K
GALDERMA GROUP AG
GALD CH1335392721 Equity 1,318 +284 1.40% $ 273.893K
QUEST DIAGNOSTICS INC DGX US74834L1008 Equity 1,125 +384 1.38% $ 270.338K
INSMED INC INSM US4576693075 Equity 1,823 −258 1.13% $ 222.078K
MADRIGAL PHARMACEUTICALS INC MDGL US5588681057 Equity 376 −54 1.04% $ 203.051K
DIANTHUS THERAPEUTICS INC DNTH US2528281080 Equity 1,761 new +1,761 0.95% $ 185.979K
BRIDGEBIO PHARMA INC BBIO US10806X1028 Equity 2,421 +207 0.95% $ 185.424K
XENON PHARMACEUTICALS INC XENE CA98420N1050 Equity 2,974 −2,003 0.91% $ 179.094K
SPYRE THERAPEUTICS INC SYRE US00773J2024 Equity 1,690 +730 0.77% $ 150.968K
DEFINIUM THERAPEUTICS INC DFTX CA24477V1058 Equity 3,695 −519 0.75% $ 146.765K
RHYTHM PHARMACEUTICALS INC RYTM US76243J1051 Equity 1,346 −192 0.73% $ 142.851K
PRAXIS PRECISION MEDICINES INC PRAX US74006W2070 Equity 406 +90 0.73% $ 142.222K
ALKERMES PLC ALKS IE00B56GVS15 Equity 2,367 −336 0.57% $ 111.225K
SARTORIUS STEDIM BIOTECH SA DIM FR0013154002 Equity 467 −66 0.54% $ 106.324K
KARDIGAN INC KARD US4859251013 Equity 4,775 new +4,775 0.49% $ 96.264K
GOLDMAN SACHS FINANCIAL SQUARE FUNDS PRIME OBLIGATIONS FUND
FGTXX Money market 94,704.09 new +94,704.09 0.48% $ 94.704K
STRUCTURE THERAPEUTICS INC GPCR US86366E1064 Equity 1,838 +830 0.43% $ 84.383K
CG ONCOLOGY INC CGON US1569441009 Equity 960 −1,472 0.37% $ 72.154K